While it may vary from person to person, most individuals experience the full effects of the medication, including significant weight loss, within about 12 to 16 weeks of consistent use
While surgery is invasive, data show it often leads to more durable weight loss compared to medication withdrawal
Further well-designed pediatric trials are essential before broader adoption can be recommended
Ideal Candidates For GLP-1 Weight Loss BMI Requirements A key factor in determining eligibility for GLP-1 weight loss treatment is body mass index (BMI)
Hair loss appeared more frequently among users of two drugs in particular: Semaglutide: 199 cases Tirzepatide: 179 cases For the remaining GLP1 medications, no elevated signal emerged: liraglutide (20 cases), dulaglutide (65 cases), exenatide (6 cases), and lixisenatide (0 cases)
222 Marina Park Way, Embarcadero Ryan Hardison is a freelance arts and entertainment writer and recent graduate of San Diego State